Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toby A Eyre

Showing results (41-50 of 161) with videos related to

Pageof 17
Sort By:
Transfusion Medicine Reviews|October 1, 2013
Interventions to reduce wrong blood in tube errors in transfusion: a systematic reviewSusan Cottrell, Douglas Watson, Toby A Eyre, et al.
Transfusion|October 15, 2013
Partial engraftment following plerixafor rescue after failed sibling donor peripheral blood stem cell harvestToby A Eyre, Andrew J King, Andrew Peniket, et al.
Histopathology|June 28, 2016
Diagnostic dilemmas of high-grade transformation (Richter's syndrome) of chronic lymphocytic leukaemia: results of the phase II National Cancer Research Institute CHOP-OR clinical trial specialist haemato-pathology central reviewElizabeth J Soilleux, Andrew Wotherspoon, Toby A Eyre, et al.
European Journal of Haematology|July 16, 2020
Efficacy and infection morbidity of front-line immuno-chemotherapy in follicular lymphomaFaouzi Djebbari, Furqaan Kaji, Louise Stanton, et al.
BMC Cancer|March 17, 2015
Single arm NCRI phase II study of CHOP in combination with Ofatumumab in induction and maintenance for patients with newly diagnosed Richter's syndromeToby A Eyre, Ruth Clifford, Corran Roberts, et al.
British Journal of Haematology|November 18, 2025
A matching-adjusted indirect comparison of survival outcomes with pirtobrutinib (BRUIN) versus standard of care (SCHOLAR-2) in relapsed/refractory mantle cell lymphoma previously treated with a covalent Bruton tyrosine kinase inhibitorGeorg Heß, Toby A Eyre, Min-Hua Jen, et al.
British Journal of Haematology|July 27, 2022
Addendum to British Society for Haematology Guideline for the management of mantle cell lymphoma, 2018 (Br. J. Haematol. 2018; 182: 46-62): Risk assessment of potential CAR T candidates receiving a covalent Bruton tyrosine kinase inhibitor for relapsed/refractory diseaseMaeve A O'Reilly, Robin Sanderson, William Wilson, et al.
American Journal of Hematology|May 29, 2021
Interpretation of retrospective data evaluating high-dose methotrexate as central nervous system prophylaxis in diffuse large B-cell lymphoma; caution requiredNicolas Martinez-Calle, Matthew R Wilson, Toby A Eyre, et al.
British Journal of Haematology|July 31, 2015
Results of a large retrospective analysis of the effect of intended dose intensity of R-CHOP on outcome in a cohort of consecutive, unselected elderly patients with de novo diffuse large B cell lymphomaToby A Eyre, Richard Salisbury, David W Eyre, et al.
American Journal of Hematology|February 27, 2015
Incidence, management, and outcome of high-grade transformation of nodular lymphocyte predominant Hodgkin lymphoma: long-term outcomes from a 30-year experienceToby A Eyre, Kevin Gatter, Graham P Collins, et al.
Pageof 17

Showing results (41-50 of 161) with videos related to

Sort By:
Pageof 17
Transfusion Medicine Reviews|October 1, 2013
Interventions to reduce wrong blood in tube errors in transfusion: a systematic reviewSusan Cottrell, Douglas Watson, Toby A Eyre, et al.
Transfusion|October 15, 2013
Partial engraftment following plerixafor rescue after failed sibling donor peripheral blood stem cell harvestToby A Eyre, Andrew J King, Andrew Peniket, et al.
Histopathology|June 28, 2016
Diagnostic dilemmas of high-grade transformation (Richter's syndrome) of chronic lymphocytic leukaemia: results of the phase II National Cancer Research Institute CHOP-OR clinical trial specialist haemato-pathology central reviewElizabeth J Soilleux, Andrew Wotherspoon, Toby A Eyre, et al.
European Journal of Haematology|July 16, 2020
Efficacy and infection morbidity of front-line immuno-chemotherapy in follicular lymphomaFaouzi Djebbari, Furqaan Kaji, Louise Stanton, et al.
BMC Cancer|March 17, 2015
Single arm NCRI phase II study of CHOP in combination with Ofatumumab in induction and maintenance for patients with newly diagnosed Richter's syndromeToby A Eyre, Ruth Clifford, Corran Roberts, et al.
British Journal of Haematology|November 18, 2025
A matching-adjusted indirect comparison of survival outcomes with pirtobrutinib (BRUIN) versus standard of care (SCHOLAR-2) in relapsed/refractory mantle cell lymphoma previously treated with a covalent Bruton tyrosine kinase inhibitorGeorg Heß, Toby A Eyre, Min-Hua Jen, et al.
British Journal of Haematology|July 27, 2022
Addendum to British Society for Haematology Guideline for the management of mantle cell lymphoma, 2018 (Br. J. Haematol. 2018; 182: 46-62): Risk assessment of potential CAR T candidates receiving a covalent Bruton tyrosine kinase inhibitor for relapsed/refractory diseaseMaeve A O'Reilly, Robin Sanderson, William Wilson, et al.
American Journal of Hematology|May 29, 2021
Interpretation of retrospective data evaluating high-dose methotrexate as central nervous system prophylaxis in diffuse large B-cell lymphoma; caution requiredNicolas Martinez-Calle, Matthew R Wilson, Toby A Eyre, et al.
British Journal of Haematology|July 31, 2015
Results of a large retrospective analysis of the effect of intended dose intensity of R-CHOP on outcome in a cohort of consecutive, unselected elderly patients with de novo diffuse large B cell lymphomaToby A Eyre, Richard Salisbury, David W Eyre, et al.
American Journal of Hematology|February 27, 2015
Incidence, management, and outcome of high-grade transformation of nodular lymphocyte predominant Hodgkin lymphoma: long-term outcomes from a 30-year experienceToby A Eyre, Kevin Gatter, Graham P Collins, et al.
Pageof 17